Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
50906-63-3	Toxyloxanthone D CC(=CCC1=CC2=C(C(=C1O)O)OC3=C(C2=O)C(=C(C(=C3)O)CC=C(C)C)O)C	C₂₃H₂₄O₆	396.4	HPLC≥95%	Click to inquire
228259-16-3	(18,19,21,22,24-Pentaacetyloxy-14,25-dihydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.01,20.03,23.07,12]pentacosa-7(12),8,10-trien-20-yl)methyl furan-3-carboxylate CC1C2=C(C=NC=C2)C(=O)OCC3(C4C(C(C5(C(C(C(C(C5(C4OC(=O)C)O3)(C)O)OC(=O)C1(C)O)OC(=O)C)OC(=O)C)COC(=O)C6=COC=C6)OC(=O)C)OC(=O)C)C	C₄₁H₄₇NO₂₀	873.8	HPLC≥95%	Click to inquire
106293-99-6	Sikokianin A COC1=CC=C(C=C1)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)C4C(OC5=CC(=CC(=C5C4=O)O)O)C6=CC=C(C=C6)O	C₃₁H₂₄O₁₀	556.5	HPLC≥95%	Click to inquire
143246-41-7	Microstegiol CC1=C2CCCC(C3(C2=C(C=C1)C=C(C3=O)C(C)C)O)(C)C	C₂₀H₂₆O₂	298.4	HPLC≥95%	Click to inquire
879324-76-2	Prionoid C CC1=CC=C2C=C(C(=O)C3=C2C1=CC(=C(C(C)C)O)O3)C(C)C	C₂₀H₂₂O₃	310.4	HPLC≥95%	Click to inquire
879324-77-3	Prionoid D CC1=C(C2=C(C=C1)C=C(C(=O)C2=O)C(C)C)C(=O)CCC(C)(C)O	C₂₀H₂₄O₄	328.4	HPLC≥95%	Click to inquire
879324-78-4	Prionoid E CC1=C(C2=C(C=C1)C=C(C(=O)C2=O)C(C)C)C(=O)C=CC(C)(C)O	C₂₀H₂₂O₄	326.4	HPLC≥95%	Click to inquire
171439-43-3	Salprionin CC1=C2C3C(CC(O3)(C)C)OC4=C2C(=CC(=C4O)C(C)C)C=C1	C₂₀H₂₄O₃	312.4	HPLC≥95%	Click to inquire
26871-46-5	(+)-Mahanimbicine CC1=CC2=C(C=C1)NC3=C2C=CC4=C3C=CC(O4)(C)CCC=C(C)C	C₂₃H₂₅NO	331.4	HPLC≥95%	Click to inquire
144606-95-1	3,8-Dimethyl-3-(4-methylpent-3-en-1-yl)-3,11-dihydropyrano[3,2-a]carbazol-9-ol CC1=CC2=C(C=C1O)NC3=C2C=CC4=C3C=CC(O4)(C)CCC=C(C)C	C₂₃H₂₅NO₂	347.4	HPLC≥95%	Click to inquire

Toxyloxanthone D

Toxyloxanthone D

C₂₃H₂₄O₆ 396.4

(18,19,21,22,24-Pentaacetyloxy-14,25-dihydroxy-3,13,14,25-tetramethyl-6,15-dioxo-2,5,16-trioxa-9-azapentacyclo[15.7.1.01,20.03,23.07,12]pentacosa-7(12),8,10-trien-20-yl)methyl furan-3-carboxylate

C₄₁H₄₇NO₂₀ 873.8

C₃₁H₂₄O₁₀ 556.5

C₂₀H₂₆O₂ 298.4

C₂₀H₂₂O₃ 310.4

C₂₀H₂₄O₄ 328.4

C₂₀H₂₂O₄ 326.4

C₂₀H₂₄O₃ 312.4

(+)-Mahanimbicine

C₂₃H₂₅NO 331.4

3,8-Dimethyl-3-(4-methylpent-3-en-1-yl)-3,11-dihydropyrano[3,2-a]carbazol-9-ol

C₂₃H₂₅NO₂ 347.4

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 16081) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号